The first consignments of the COVID vaccine produced by Johnson & Johnson began arriving in European Union countries on Monday, EU officials and the company have announced.
The EU is expected to receive 55 million doses of the long-awaited vaccine by June.
The vaccine, which Malta has reserved 250,000 doses of, was approved for use by the EMA in March.
It comes as Malta’s vaccine program continues to roar ahead of those of its neighbours. On Saturday, Deputy Prime Minister and Minister for Health Chris Fearne announced that the country is projected to receive herd immunity by the end of June.
So far, a total of 244,718 COVID vaccine doses have been administered in Malta, of which 71,481 were second doses.
The Johnson & Johnson vaccine is produced by Janssen, a Belgium-based subsidiary of the US pharma giants.
It is notable in that it is the first which is effective after a single dose, thus simplifying its rollout.
A clinical trial has shown the vaccine to have an efficacy rate of 67 per cent.
Cautious optimism across sectors: Business confidence rebounds in Q1 2025, says Central Bank
Confidence is creeping back into Malta’s business community
Government unveils new framework to establish ‘national one-stop-shop for startups’
Emerging companies will be able to access the necessary support, such as an enhanced share awards and stock option scheme
Aviation leaders warn EU and local policies are jeopardising Malta connectivity
An event hosted by the MBN in collaboration with the IBN explored the challenges facing the tourism industry